Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA approvals
Pharma
Vanda, Agios score holiday season FDA approvals
The FDA delivered a pair of holiday season nods, signing off on Agios’ Aqvesme for thalassemia and Vanda's motion sickness pill Nereus.
Kevin Dunleavy
Jan 2, 2026 11:33am
FDA signs off on 1st gene therapy for rare genetic disease
Dec 10, 2025 12:09pm
2025 approvals: Biopharma delivered 55 new drugs, biologics
Brought to you by
Real Chemistry
FDA safety probe, Otsuka, ADC patent fight—Fierce Pharma Asia
Dec 5, 2025 8:45am
Otsuka wins FDA nod in ever-more-crowded kidney disease space
Nov 26, 2025 11:10am
Regeneron wins 2 Eylea nods, ramping up competition with Roche
Nov 20, 2025 11:53am
